​

Neumora Therapeutics Ownership | Who Owns Neumora Therapeutics?

OverviewForecastFinancialsChartTranscripts

Neumora Therapeutics Ownership Summary

Neumora Therapeutics is owned by 50.43% institutional investors, 27.60% insiders, and 21.98% retail investors. Gamma investing is the largest institutional shareholder, holding 0% of NMRA shares.

NMRA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockNeumora Therapeutics50.43%27.60%21.98%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Gamma investing---
Versant capital management---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Gamma investing---
Versant capital management---

Top Buyers

HolderShares% AssetsChange
Gamma investing---16.00
Versant capital management---421.00

Top Sellers

HolderShares% AssetsChange
Versant capital management---421.00
Gamma investing---16.00

Sold Out

HolderChange
Gamma investing-16.00
Versant capital management-421.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202416443.86%80,367,33617.21%502.73%9253.33%3357.14%
Sep 30, 202411418.75%68,568,1827.43%422.67%60-10.45%2161.54%
Jun 30, 2024969.09%63,827,34521.38%403.62%6728.85%13-23.53%
Mar 31, 20248837.50%52,586,59620.20%334.39%5220.93%17112.50%
Dec 31, 20236468.42%43,747,88820.34%275.03%4313.16%8-

Recent Insider Transactions

DateNameRoleActivityValue
Feb 18, 2025BERNS PAUL L See RemarksSell$23.47K
Feb 18, 2025Milligan Michael Lee See RemarksSell$3.35K
Feb 18, 2025Aurora Daljit Singh Chief Strategy OfficerSell$14.35K
Feb 18, 2025Lenz Robert A. Head of R&DSell$9.38K
Feb 18, 2025Pinto Joshua PresidentSell$13.48K

Insider Transactions Trends

DateBuySell
2025 Q1-5
2024 Q4-4
2024 Q3-3
2023 Q420-
2023 Q319-

NMRA Ownership FAQ

Who Owns Neumora Therapeutics?

Neumora Therapeutics shareholders are primarily institutional investors at 50.43%, followed by 27.60% insiders and 21.97% retail investors. The average institutional ownership in Neumora Therapeutics's industry, Biotech Stocks , is 68.48%, which Neumora Therapeutics falls below.

Does Blackrock own Neumora Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Neumora Therapeutics.

Who is Neumora Therapeutics’s biggest shareholder by percentage of total assets invested?

Gamma investing is Neumora Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Neumora Therapeutics shares, valued at 0$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools